Stay updated with breaking news from Nasdaq agen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research analysts at StockNews.com started coverage on shares of Agenus (NASDAQ:AGEN – Get Free Report) in a note issued to investors on Wednesday. The firm set a “hold” rating on the biotechnology company’s stock. Several other brokerages also recently commented on AGEN. B. Riley dropped their target price on shares of Agenus from $120.00 to […] ....
Agenus (NASDAQ:AGEN – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Sunday. Several other brokerages have also commented on AGEN. B. Riley decreased their price objective on shares of Agenus from $6.00 to $5.00 and set a “buy” […] ....
Agenus (NASDAQ:AGEN – Get Free Report) is scheduled to announce its earnings results before the market opens on Thursday, March 14th. Analysts expect the company to announce earnings of ($0.06) per share for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link. Agenus Price Performance […] ....
Agenus Inc. (NASDAQ:AGEN – Get Free Report) insider Garo H. Armen bought 500,000 shares of the firm’s stock in a transaction dated Thursday, February 15th. The stock was purchased at an average price of $0.65 per share, for a total transaction of $325,000.00. Following the transaction, the insider now owns 625,969 shares of the company’s […] ....
BNP Paribas Arbitrage SNC lowered its position in Agenus Inc. (NASDAQ:AGEN – Free Report) by 61.8% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 360,232 shares of the biotechnology company’s stock after selling 582,214 shares during the period. BNP Paribas Arbitrage SNC owned 0.10% of […] ....